Dr. Tal Yossefi, a graduate of the University of Pennsylvania, and Dr. Elad Yossefi, who earned his degree from NYU and the ...

The Offering is being conducted on a firm commitment basis. Joseph Stone Capital, LLC is acting as sole underwriter for the Offering (the “Underwriter”). Sichenzia Ross Ference Carmel LLP is acting as ...

Finnish-Australian health technology company Agora, founded by Elizabeth Angel and Dr Olivia Lesslar, has officially launched ...

The Company Recently Announced Successful Topline Results from its Phase 3 SHIELD II Trial; D-PLEX₁₀₀ Demonstrated a Statistically Significant Reduction in Surgical Site Infections (“SSIs”) and ...

The Association of American Physicians and Surgeons (AAPS) filed its amicus brief in the U.S. Supreme Court on June 12 against a Colorado ban on conversion therapy for minors, in Chiles v. Salazar (No ...

All of the above-described awards were granted as an inducement material to each employee’s acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635 (c) (4). The options have a ...

It’s a reckoning and an opportunity to restore public trust in health innovation by delivering life-saving tools to the people who need them most with all of that information on our website.” ...

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has entered into a collaboration and license agreement ...

In the article, Murphy outlines how the rise in autism diagnoses, the high rates of medical complexity among autistic people and the shortage of autism specialists are driving the urgent need for new ...

Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announces that today it has filed and obtained a receipt for a preliminary short form base shelf prospectus with the securities ...

MediPharm wishes to assure its shareholders that as the Meeting has not yet taken place, the results are not yet available. MediPharm will announce the final results of the Meeting in the ordinary ...